Quantitative analysis of vascular endothelial growth factor and pigment epithelium-derived factor in aqueous humor before and after intravitreal injection of ranibizumab in proliferative diabetic retinopathy
- Author:
- No author available
- Journal Title:
- Chinese Journal of Ocular Fundus Diseases
- Issue:
- 6
- DOI:
- 10.3760/cma.j.issn.1005-1015.2015.06.012
- Key Word:
- 糖尿病视网膜病变/药物疗法;血管生成抑制剂/治疗应用;抗体,单克隆/治疗应用;血管内皮生长因子类;Diabetic retinopathy/drug therapy;Angiogenesis inhibitors/therapeutic use;Antibodies,monoclonal/therapeutic use;Vascular endothelial growth factors
Abstract： Objective To analyze the concentrations of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in aqueous humor of patients with proliferative diabetic retinopathy (PDR) before and after intravitreal injection of ranibizumab.Methods Twenty-five eyes of 20 PDR patients were collected as the PDR group.Twenty-five eyes of 21 senile cataract patients were collected as the control group.There were no statistical significance in gender (x2 =0.223), age (Z=-1.555) and intraocular pressure (Z=0.225) between the two groups (P＞0.05).Samples of aqueous humor (0.1 ml) were collected just before and 7 days after the injection of ranibizumab in PDR group.Samples of aqueous (0.1 ml) humor were collected just before cataract surgery in control group.The concentrations of VEGF and PEDF in the aqueous humor were measured by enzyme-linked immunosorbent assay.Results The VEGF and PEDF concentration in the aqueous humor were reduced significantly after intravitreal injection of ranibizumab in PDR group (Z=-4.072,-4.319;P＜0.05).The concentrations of VEGF and PEDF in the aqueous humor before intravitreal injection of ranibizumab in PDR group were significantly higher than the control group (Z=-5.228, 4.706;P＜0.05).The VEGF concentration in the aqueous humor after intravitreal injection of ranibizumab in PDR group were similar to control group (Z=-1.557,P＞ 0.05).However, the concentration of PEDF in the aqueous humor after intravitreal injection of ranibizumab in PDR group still higher than control group (Z=-2.475, P＜0.05).The ratio of VEGF/PEDF before and after intravitreal injection of ranibizumab was statistically different (Z=-2.058, P＜0.05), but was the same between PDR group and control group (Z=-0.456,-0.844;P＞0.05).The aqueous humor concentrations of VEGF and PEDF were not significantly correlated with each other, neither in PDR group (r=-0.195,-0.174;P＞0.05) nor in control group (r=-0.286, P＞0.05).Conclusions Aqueous humor concentrations of VEGF and PEDF are significantly elevated in eyes with PDR.Intravitreal injection of ranibizumab significantly decreased the VEGF and PEDF in the aqueous humor after 7 days.
- [1].糖尿病的诊断和分型[J].2000,(1).
- [2]EUGENE W.M. NG,ANTHONY P. ADAMIS.Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases[J].2006,1082(oct).
- [3]Unterlauft, Jan Darius,Claudepierre, Thomas,Schmidt, Manuela,etc.Enhanced survival of retinal ganglion cells is mediated by Muller glial cell-derived PEDF[J].2014,127.
- [4]Maberley, David A. L.,Simunovic, Matthew P..ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY A Systematic Review and Meta-Analysis[J].2015,35(10).
- [5]Hideharu Funatsu,Hidetoshi Yamashita,Hidetaka Noma,etc.Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients[J].2005,243(1).
- [6]Wang, Jia Wei,Zhou, Min Wen,Zhang, Xiulan,etc.Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma[J].2015,43(5).
- [7]Matsuoka M,Takahashi K,Ogata N,etc.Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab.[J].2010,94(9).
- [8]Matsuoka M,Minamino K,Ogata N,etc.Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy.[J].2006,50(2).
- [9]Jae Kyoun Ahn,Hyung Jin Moon.Changes in Aqueous Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor after Ranibizumab Alone or Combined with Verteporfin for Exudative Age-related Macular Degeneration[J].2009,148(5).
- [10]Ogata, N.,Nishikawa, M.,Nishimura, T.,etc.Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy[J].2002,134(3).
- [11]Narayanasamy, Angayarkanni,Radhakrishnan, Selvi,Rishi, Pukhraj,etc.Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.[J].2009,2(1).
- [12]Krohne,T.U.,Liu,Z.,Holz,F.G.,etc.Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans[J].2012,154(4).
- [13]Elahy,M.,Baindur-Hudson,S.,Cruzat,V.F.,etc.Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy[J].2014,222(3).
- [14]Kyoko Ohno-Matsui,Takeshi Yoshida,Tomoko Uetama,etc.Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells[J].2003,303(3).
- [15]N, Gupta,S, Mansoor,A, Sharma,etc.Diabetic retinopathy and VEGF.[J].2013,7.